Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
1/4B traded....who's buying...does anyone have the last weeks total volume traded?
The agreement with YA, as I understand it, forbids a reverse split.
thanks Sal :)
Does anyone have the current OS ?
I consider many things a PUMP (not here though....and, imo, the LOW pps reflects it), but an 8k, I wouldn't consider that even remotely as a pump---can you explain why you think it is? TIA Sal
BioNeutral Group's YGIENE(TM) 206 Sterilant Offers High Performance Alternative for Ebola Surface Decontamination
Accesswire
59 minutes ago
????
NEWARK, NJ / ACCESSWIRE / October 21, 2014 / BioNeutral Group Inc. (OTC Pink: BONU) (BONU), a specialty life science technology based company today addressed the Ebola decontamination issue. Surfaces contaminated with Ebola pose a threat in the spread of this disease. While other disinfectants may be used to decontaminate surfaces containing Ebola, the Company believes that none can offer the level of decontamination efficacy and efficiency offered by YGIENE(TM) 206 Sterilant which eliminates all harmful microorganisms. YGIENE(TM) 206 Sterilant is the fastest ready to use sterilant with a 20 minute kill time, and is chlorine and aldehyde free. YGIENE(TM) 206 Sterilant provides an extra level of confidence in eliminating Ebola in addition to other harmful microorganisms on contaminated surfaces either by wetting surfaces or immersing contaminated articles.
YGIENE(TM)Sterilant/Disinfectant is registered with the US EPA as a sterilant with a 20 minute contact time. As a sterilant, YGIENE(TM) 206 kills all harmful microbial life including Ebola as long as the nonporous surface has contact with YGIENE(TM) for the full 20 minutes.
As indicated on the YGIENE(TM) 206 Sterilant label: "a sterilizer is an antimicrobial pesticide that destroys or eliminates all forms of microbial life in the inanimate environment, including bacterial spores. The term "sporicide" is deemed to be synonymous with "sterilizer". Since sterilization includes eradication of all living microorganisms, such claims are intrinsically related to protection of human health (EPA DIS/TSS-9)."
The Company believes that the ease of application and this high level of broad spectrum efficacy sets the ready to use YGIENE(TM) 206 Sterilant apart from other available disinfectants.
About BioNeutral Group, Inc.:
Headquartered in Newark, New Jersey, BioNeutral Group, Inc., is a specialty technology-based life-science company that has developed a technology platform that neutralizes harmful environmental contaminants, toxins and dangerous micro-organisms including bacteria, viruses, mold, fungi and spores. BioNeutral's products, YGIENE(TM) and OGIENE(TM), kill germs and clean surfaces with a dramatic increase in speed and power over their rivals in the marketplace. BioNeutral's proprietary platform technology has been proven effective in surface, water and airborne applications. Its antimicrobial line of products under the YGIENE(TM) brand have been approved by the EPA for sale in the United States. For more information on BioNeutral, including a listing of company products, leadership and background please visit www.bioneutral.com.
Find us on Facebook: http://www.facebook.com/pages/BioNeutral-Group/149109938452393
Follow us on Twitter: http://twitter.com/bioneutralgroup
Forward-Looking Statements:
This release contains certain "forward-looking statements" relating to the business of the Company and its subsidiary companies. These forward-looking statements are often identified by the use of forward-looking terminology such as "believes," "expects" or similar expressions. Such forward-looking statements involve known and unknown risks and uncertainties that may cause actual results to be materially different from those described herein as anticipated, believed, estimated or expected. Investors should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including those described in the Company's filings with the Securities and Exchange Commission. BioNeutral routinely tests its formulations against those of its competitors. The results are published to let shareholders know how the Company's technology compares with known formulations in the market place. Any product claim for antimicrobial activity requires approval from the EPA or FDA, depending upon where and how the formulations are used. The EPA has approved and registered the Company's data and findings specific to YGIENE(TM)206 Sterilant. BioNeutral's antimicrobial formulations will be marketed under the brand name YGIENE(TM) and are available for sale in the United States.
CONTACT:
Mark Lowenthal
CEO and Sales Information for BioNeutral Group, Inc.
+1-973-577-8003
SOURCE: BioNeutral Group, Inc.
Lets hope there will be one
look at the trade at 15:08:50 today for 100,000 shares sold at -1.00 unknown exchange and condition norm----what does that mean?
AGREED....at this point all we can do is keep our fingers X'd
Me TO Sal----could be a big mistake, but still worth a chance.
Thanks NYBob---for more great DD
strange that this gets posted last evening when yesterday the pps was falling
Great to see some talk on here :) But, anyone have any ideas on what is going on....What are they waiting for w/the RS----do we just sit here and wait for activity to begin again....hopefully begin again?
How about this,
If he kept selling the maximum amount, there is a good CHANCE the SEC would get involved.
instead of
Quote:
If he kept selling the maximum amount SEC would get involved.
Point is...They already may be involved IMO
I would say....right now... is MORE than appropriate!
He stated it himself
I find it very odd that it was there for that length of time, and now it was decided by a third party it was unacceptable----I am not sure mainly because Mave is not around to say otherwise, that he himself may have asked for it to be removed----I am long here...do not get me wrong, I hope I AM WRONG
Has anyone figured out why Mave's sticky is gone?
Excellent Vort---next question to them should be-----WELL?...... Are they getting the exposure of the product out there? CDC, Gov, airline, etc
No ask, no bid, no nothing----what is going on?
That is actually a little concerning, why would he take that down?
What land at location #1 does FITX own.......0
friends???? or family/in-laws/distant cousins of in-laws etc
Will we be notified if it happens? and will we have a new ticker symbol?
Ram and Malt---excuse my novice questions---Can any authority such as SEC or FINRA stop a reverse split in the pinks? Also, Malt, the AS increase you are referring to as not taking place, was that the increase to 36 billion?
Are there any mods on this board----I was under the impression that personal attacks, knowingly posting untruths, etc were not allowed---and would/could result in being suspended from posting
VOLUME.......I wonder why
Personal attacks are ridiculous here----we are all in the same boat.....hoping for a miracle----we need one!
Thanks for all the DD NYBob!
Reporting out-----
On July 23, 2014, the Company filed a Schedule 14C Information Statement with the SEC to notify the stockholders of the Company of Management’s plan to increase the number of authorized shares of common stock from seventeen billion (17,000,000,000) to thirty seven billion (37,000,000,000) shares with the Secretary of State of Nevada. At a meeting held on July 21, 2014, the Company received unanimous consent by the Board and by the holder of Series F Preferred Stock, no par value per share (the “Series F Preferred”), and authorized management to increase the number of shares authorized to thirty seven billion (37,000,000,000) shares. The additional twenty billion (20,000,000,000) shares of Common Stock so authorized would have been available for issuance by the Board for stock splits or stock dividends, acquisitions, raising additional capital, stock options or other corporate purposes. The additional shares of Common Stock could be used for potential strategic transactions, including, among other things, acquisitions, strategic partnerships, joint ventures, restructurings, business combinations and investments, although there are no immediate plans to do so. Assurances cannot be provided that any such transactions will be consummated on favorable terms or at all, that they will enhance stockholder value or that they will not adversely affect the Company's business or the trading price of the Common Stock. The authorized share increase was withdrawn when the Company filed a Schedule 14C Information Statement with the SEC on August 18, 2014 to notify the stockholders of the Company of Management’s plan to amend the Company’s Articles of Incorporation, as amended, to effectuate a 1,000-to-1 reverse split of the Company’s Common Stock, par value $.00001 per share. The Company currently has not effectuated the increase in the authorization of its common stock from 17,000,000,000 to 37,000,000,000. At the current range of market trading prices of the Company’s common stock, the Company does not possess enough authorized stock to convert all of its convertible instruments to common stock. For the Company to meet all of its obligations upon the receipt of notices of conversion received from noteholders, the Company will need to increase the authorized limit of common stock.
Totally agreed Ram!
news---Late filing
PART II
RULE 12b-25 (b) AND (c)
If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25 (b), the following should be completed. (Check box if appropriate.)
T (a) The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
(b) The subject annual report, semi-annual report, transition report on Form 10-K, 20-F, 11-K or Form 10-Q, or portion thereof will be filed on or before the 15th calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q, or portion thereof will be filed on or before the fifth calendar day following the prescribed due date; and
(c) The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.
PART III
NARRATIVE
State below in reasonable detail the reasons why Form 10-K, 11-K, 20-F, 10-Q, N-SAR or the transition report portion thereof could not be filed within the prescribed time period.
Despite diligent efforts exerted by management, BioNeutral Group, Inc.’s (the “Company”) Quarterly Report on Form 10-Q for the fiscal period ended July 31, 2014 could not be completed without unreasonable effort and expense. Such difficulties prevent the Company from filing the report because the information being completed is integral to the balance of the report. The Company expects to be able to file within the additional time allowed.
PART IV
OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to this notification
Mark Lowenthal (973) 577-8003
(Name) (Area Code) (Telephone Number)
(2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If the answer is no, identify report(s).
T Yes ¨ No
(3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?
o Yes x No
If so: attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.
2
BioNeutral Group, Inc.
Name of Registrant as Specified in Charter.
Has caused this notification to be signed on its behalf by the undersigned thereunto duly authorized.
Dated: September 11, 2014 By: /s/ Mark Lowenthal
Name: Mark Lowenthal
Title:
President, Chief Executive Officer
and Principal Accounting Officer
please provide a link/proof
Sean---why does a RS signal end of dilution?
I was under the impression that we have NO voting shares
better than nothing
If this is the case, what actually happens if you hold and do not sell back---are you forced to sell/turn in shares?
pleasantly surprised to see some volume!
I beg to differ....EPA is one governmental agency that goes against 'the grain'---I do not think they can 'be greased'
http://www.epa.gov/epawaste/hazard/testmethods/methdev.htm
http://ofmpub.epa.gov/sor_internet/registry/datastds/findadatastandard/epaapproved/
Sal do you know what the catalyst was that caused the drop from .09 downward?